Quantra QStat in Trauma and Liver Transplant

NCT04312958 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 397

Last updated 2023-05-03

No results posted yet for this study

Summary

This is a multi-center prospective, observational study of the Quantra System with the QStat Cartridge in trauma patients and patients undergoing liver transplant.

Conditions

Interventions

DIAGNOSTIC_TEST

Quantra System

Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.

Sponsors & Collaborators

  • HemoSonics LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-20
Primary Completion
2022-12-31
Completion
2023-04-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04312958 on ClinicalTrials.gov